- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07522814
"Educatieve interventie voor tokofobie bij zwangere vrouwen" (TOKO-EDU)
Changes in Tokophobia Awareness, Fear of Childbirth, Coping Strategies, and Quality of Life Following Structured Educational Sessions Among Pregnant Women: A Quasi-Experimental Single-Group Pretest-Posttest Study
This quasi-experimental single-group pretest-posttest study examined immediate within-participant differences in tokophobia awareness, fear of childbirth, reported coping-strategy use, and quality of life among 50 pregnant women attending the antenatal outpatient clinics of Soad Kafafi Hospital, 6th of October City, Giza, Egypt.
Participants attended a standardized program comprising ten face-to-face sessions delivered twice weekly over five weeks. Each session lasted approximately 45-60 minutes, including orientation, baseline assessment, educational activities, review, and post-intervention evaluation.
Outcomes were assessed using the researcher-developed Tokophobia Awareness Questionnaire (TAQ), an Arabic translation of the Fear of Childbirth Questionnaire (FCQ), the Jalowiec Coping Scale (JCS), and WHOQOL-BREF. Baseline measures were completed before educational content was delivered. Post-intervention assessment took place immediately after the final session on the same day. No longer-term follow-up was conducted.
The absence of a comparison group prevents causal attribution of the observed differences to the educational sessions.
Studie Overzicht
Toestand
Interventie / Behandeling
Gedetailleerde beschrijving
The study used a quasi-experimental single-group pretest-posttest design. Fifty pregnant women participated in the main study. Five separate women participated in pilot testing and were excluded from the main-study sample and analysis.
The main-study participants were divided into ten groups of five. The same educator, specializing in obstetric and gynecological health nursing, delivered the standardized program separately to each group. Other research-team members administered and collected the outcome questionnaires.
Each participant attended ten sessions over five consecutive weeks, with two sessions per week and approximately 45-60 minutes per session. Session 1 covered study orientation and procedures. Session 2 included baseline assessment, completed before delivery of educational content. Sessions 3-8 addressed tokophobia-related knowledge, childbirth preparation, coping strategies, stress management, communication, and professional and social support. Session 9 covered review and reinforcement. Session 10 included final reinforcement and immediate post-intervention assessment.
The TAQ assessed factual knowledge and awareness of tokophobia. The FCQ assessed self-reported fear of childbirth rather than establishing a clinical diagnosis of tokophobia. The JCS assessed frequency of coping-strategy use, and WHOQOL-BREF assessed self-reported quality of life across four domains.
No single primary outcome was prospectively designated. The continuous FCQ total score was prioritized for interpretation during manuscript revision. Analyses are exploratory because the study lacked a comparison group and multiple tests were conducted without adjustment.
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Giza Governorate
-
Cairo, Giza Governorate, Egypte, 12566
- Soad Kafafi Hospital
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Pregnant women aged 18 years or older.
- Attending the antenatal outpatient clinics at the study setting.
- Willing to participate and provide informed consent.
Exclusion Criteria:
- Diagnosed severe or acute psychiatric disorders that could interfere with study participation.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ander
- Toewijzing: NVT
- Interventioneel model: Opdracht voor een enkele groep
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Educational Intervention Group
Pregnant women attended a standardized ten-session educational program delivered face-to-face in groups of five, twice weekly over five weeks. Each session lasted approximately 45-60 minutes, including orientation, assessment, educational activities, review, and evaluation. Educational content addressed tokophobia awareness, childbirth preparation, coping strategies, relaxation, stress management, and available professional and social support. |
A structured educational program designed to provide information about tokophobia, its causes, symptoms, and management, along with training on psychological coping strategies and supportive techniques to enhance maternal well-being.
Andere namen:
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in Fear of Childbirth Questionnaire (FCQ) Total Score
Tijdsspanne: Baseline (Session 2, before educational content) and immediately after Session 10, at the end of the five-week program.
|
Change in the 20-item FCQ total score from baseline to immediate post-intervention assessment. Items are scored 0-3, with positively worded items reverse-scored. Total scores range from 0 to 60; higher scores indicate greater fear of childbirth. The Arabic translation used in this study underwent preliminary linguistic and cultural adaptation. |
Baseline (Session 2, before educational content) and immediately after Session 10, at the end of the five-week program.
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in Tokophobia Awareness Questionnaire (TAQ) Total Score
Tijdsspanne: Baseline (Session 2, before educational content) and immediately after Session 10, at the end of the five-week program.
|
Change in the researcher-developed 23-item TAQ total score from baseline to immediate post-intervention assessment. Correct responses are scored 1 and incorrect responses 0. Total scores range from 0 to 23; higher scores indicate greater factual knowledge and awareness of tokophobia. |
Baseline (Session 2, before educational content) and immediately after Session 10, at the end of the five-week program.
|
|
Change in Jalowiec Coping Scale (JCS) Total Score
Tijdsspanne: Baseline (Session 2, before educational content) and immediately after Session 10, at the end of the five-week program.
|
Change in the 40-item JCS total score from baseline to immediate post-intervention assessment. Items are scored from 1 to 5, producing total scores ranging from 40 to 200. Higher scores indicate more frequent self-reported coping-strategy use. |
Baseline (Session 2, before educational content) and immediately after Session 10, at the end of the five-week program.
|
|
Change in WHOQOL-BREF Domain Scores
Tijdsspanne: Baseline (Session 2, before educational content) and immediately after Session 10, at the end of the five-week program.
|
Changes from baseline to immediate post-intervention assessment in the four WHOQOL-BREF domains: physical health, psychological health, social relationships, and environment. Each domain score is transformed to a 0-100 scale, with higher scores indicating better self-reported quality of life. The four domains are analyzed separately. |
Baseline (Session 2, before educational content) and immediately after Session 10, at the end of the five-week program.
|
Medewerkers en onderzoekers
Onderzoekers
- Hoofdonderzoeker: Basma W Elrefay, phd, Delta University for Science and Technology, Egypt
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- DU-TOKO-2025-01
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
Individual participant data (IPD) will not be made publicly available due to privacy, confidentiality, and ethical restrictions related to the study participants.
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .